Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Kanz

Showing results (141-150 of 241) with videos related to

Pageof 25
Sort By:
British Journal of Cancer|February 13, 2001
A randomized trial of amifostine in patients with high-dose VIC chemotherapy plus autologous blood stem cell transplantationJ T Hartmann, A von Vangerow, L M Fels, et al.
World Journal of Urology|January 1, 1996
The role of paclitaxel in chemosensitive urological malignancies: current strategies in bladder cancer and testicular germ-cell tumorsC Bokemeyer, J T Hartmann, M A Kuczyk, et al.
British Journal of Haematology|July 1, 1993
Peripheral blood progenitor cells mobilized by chemotherapy plus granulocyte-colony stimulating factor accelerate both neutrophil and platelet recovery after high-dose VP16, ifosfamide and cisplatinW Brugger, R Birken, H Bertz, et al.
Annals of the New York Academy of Sciences|June 18, 1999
Expression of novel surface antigens on early hematopoietic cellsH J Bühring, M Seiffert, T A Bock, et al.
British Journal of Cancer|March 1, 2002
Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [(18)F]FDG PETC Bokemeyer, C Kollmannsberger, K Oechsle, et al.
British Journal of Cancer|May 14, 1998
Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancerC Bokemeyer, C C Berger, J T Hartmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancerS Fetscher, W Brugger, R Engelhardt, et al.
Bone Marrow Transplantation|December 1, 1996
Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donorsJ Finke, W Brugger, H Bertz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Treatment of brain metastases in patients with testicular cancerC Bokemeyer, P Nowak, A Haupt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
A phase I study of oral uracil-ftorafur plus folinic acid in combination with weekly paclitaxel in patients with solid tumorsF Mayer, J T Hartmann, J von Pawel, et al.
Pageof 25

Showing results (141-150 of 241) with videos related to

Sort By:
Pageof 25
British Journal of Cancer|February 13, 2001
A randomized trial of amifostine in patients with high-dose VIC chemotherapy plus autologous blood stem cell transplantationJ T Hartmann, A von Vangerow, L M Fels, et al.
World Journal of Urology|January 1, 1996
The role of paclitaxel in chemosensitive urological malignancies: current strategies in bladder cancer and testicular germ-cell tumorsC Bokemeyer, J T Hartmann, M A Kuczyk, et al.
British Journal of Haematology|July 1, 1993
Peripheral blood progenitor cells mobilized by chemotherapy plus granulocyte-colony stimulating factor accelerate both neutrophil and platelet recovery after high-dose VP16, ifosfamide and cisplatinW Brugger, R Birken, H Bertz, et al.
Annals of the New York Academy of Sciences|June 18, 1999
Expression of novel surface antigens on early hematopoietic cellsH J Bühring, M Seiffert, T A Bock, et al.
British Journal of Cancer|March 1, 2002
Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [(18)F]FDG PETC Bokemeyer, C Kollmannsberger, K Oechsle, et al.
British Journal of Cancer|May 14, 1998
Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancerC Bokemeyer, C C Berger, J T Hartmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancerS Fetscher, W Brugger, R Engelhardt, et al.
Bone Marrow Transplantation|December 1, 1996
Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donorsJ Finke, W Brugger, H Bertz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Treatment of brain metastases in patients with testicular cancerC Bokemeyer, P Nowak, A Haupt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
A phase I study of oral uracil-ftorafur plus folinic acid in combination with weekly paclitaxel in patients with solid tumorsF Mayer, J T Hartmann, J von Pawel, et al.
Pageof 25